Sterling Hospitals CFO Highlights Key Healthcare Priorities Ahead of Union Budget

Ahmedabad (Gujarat) [India], January 29: Ahead of the Union Budget, Sterling Hospitals emphasized the need for sustained and targeted investments in India’s healthcare sector to strengthen delivery capacity, improve affordability and support long term system resilience.

Mr. Amrendra Kumar Gupta, Chief Financial Officer, Sterling Hospitals, said that enhancing public healthcare allocation will play a crucial role in ensuring smoother implementation of government health schemes and improving patient outcomes.

“An increase in allocation for public healthcare programs such as Ayushman Bharat will help
streamline payments, support hospital operations and enable healthcare providers to
continue delivering quality care at scale,” said Mr. Amrendra Kumar Gupta.

He noted that aligning healthcare spending with the National Health Policy’s long term target of 2.5% of GDP would provide the necessary momentum for infrastructure development, technology adoption and workforce expansion across the sector.

Mr. Amrendra Kumar Gupta also highlighted the importance of budgetary incentives for
private hospitals to invest in capacity building and skilled manpower development, including
nursing, ICU care professionals, allied healthcare staff and medical technicians. “Focused
incentives for training and scaling allied healthcare professionals can help address skill
gaps, improve operational efficiency and reduce overall healthcare delivery costs, directly
benefiting patients,” he added.

On the technology front, Sterling Hospitals advocated tax support for indigenously developed medical devices and AI enabled healthcare solutions, which can reduce dependency on imported equipment and lower long term capital and maintenance costs for hospitals.

“Encouraging domestic innovation in medical devices and digital healthcare will strengthenself-reliance while improving affordability and access,” Mr. Amrendra Kumar Gupta said.

The hospital group also underlined the need for faster regulatory clearances for indigenous drug development and clinical research, enabling quicker response during public health emergencies and supporting India’s growing life sciences ecosystem.

In addition, Mr. Gupta suggested strengthening governance mechanisms under public health schemes to enable time bound resolution of health insurance and reimbursement related
issues, easing financial stress for hospitals and patients alike.

Sterling Hospitals reiterated that a balanced Budget approach focused on higher healthcare investment, private sector participation, domestic innovation and efficient governance will support sustainable growth of India’s healthcare system and enhance patient care delivery nationwide.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More